Jupiter Life Line Hospital Intrinsic Value
JLHL Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹420.00 | ₹336.00 - ₹504.00 | -68.2% | EPS: ₹35.00, Sector P/E: 12x |
| Book Value Method | asset | ₹263.84 | ₹237.46 - ₹290.22 | -80.0% | Book Value/Share: ₹205.45, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹395.76 | ₹356.18 - ₹435.34 | -70.0% | Revenue/Share: ₹245.45, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹527.68 | ₹474.91 - ₹580.45 | -60.0% | EBITDA: ₹416.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹527.68 | ₹422.14 - ₹633.22 | -60.0% | CF Growth: 15.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹395.76 | ₹356.18 - ₹435.34 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹395.76 | ₹356.18 - ₹435.34 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹659.60 | ₹593.64 - ₹725.56 | -50.0% | ROE: 17.1%, P/E Multiple: 14x |
| Graham Defensive Method | conservative | ₹402.24 | ₹362.02 - ₹442.46 | -69.5% | EPS: ₹35.00, BVPS: ₹205.45 |
Want to compare with current market value? Check JLHL share price latest .
Valuation Comparison Chart
JLHL Intrinsic Value Analysis
What is the intrinsic value of JLHL?
Based on our comprehensive analysis using 9 different valuation methods, the estimated intrinsic value of Jupiter Life Line Hospital (JLHL) is ₹402.24 (median value). With the current market price of ₹1319.20, this represents a -69.5% variance from our estimated fair value.
The valuation range spans from ₹263.84 to ₹659.60, indicating ₹263.84 - ₹659.60.
Is JLHL undervalued or overvalued?
Based on our multi-method analysis, Jupiter Life Line Hospital (JLHL) appears to be trading above calculated value by approximately 69.5%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 1.73 | Industry Standard: 2.0+ | Above 1.5 | Measures short-term liquidity capacity |
| Debt to Equity Ratio | 1.40 | Industry Standard: <0.5 | Above 1.0 | Indicates financial leverage level |
| Return on Equity | 17.1% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 23.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.85x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Jupiter Life Line Hospital
Additional stock information and data for JLHL
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹253 Cr | ₹149 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹115 Cr | ₹-8 Cr | Positive Operating Cash Flow | 6/10 |
| March 2023 | ₹117 Cr | ₹65 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹137 Cr | ₹95 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹123 Cr | ₹-25 Cr | Positive Operating Cash Flow | 6/10 |